Albert L. Reese Jr. - 15 May 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Albert Reese Jr./
Issuer symbol
LEXX
Transactions as of
15 May 2025
Net transactions value
$0
Form type
4
Filing time
16 May 2025, 16:30:40 UTC
Previous filing
30 Jul 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
REESE ALBERT L JR Director /Albert Reese Jr./ 16 May 2025 0001244736

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 10,917 15 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +11,000 +34% $0.000000 43,000 15 May 2025 Common Shares 11,000 $1.04 Direct
holding LEXX Stock Options 3,400 15 May 2025 Common Shares 3,400 $3.00 Direct
holding LEXX Stock Options 6,800 15 May 2025 Common Shares 3,400 $3.39 Direct
holding LEXX Stock Options 10,000 15 May 2025 Common Shares 3,200 $1.96 Direct
holding LEXX Stock Options 15,000 15 May 2025 Common Shares 5,000 $0.8700 Direct
holding LEXX Stock Options 20,000 15 May 2025 Common Shares 5,000 $2.36 Direct
holding LEXX Stock Options 32,000 15 May 2025 Common Shares 12,000 $3.39 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.